Cargando…
Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells
Cancer stem cells (CSCs) are characterized by self-renewal and unlimited proliferation, providing a basis for tumor occurrence, metastasis, and recurrence. Because CSCs are highly resistant to conventional chemotherapy and radiotherapy, various immunotherapies, particularly chimeric antigen receptor...
Autores principales: | Liu, Liu, Liu, Yuanyuan, Xia, Yang, Wang, Guanlong, Zhang, Xiushan, Zhang, Huan, Xu, Yang, Yuan, Yuan, Liu, Shangquan, Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517999/ https://www.ncbi.nlm.nih.gov/pubmed/34659553 http://dx.doi.org/10.7150/jca.62123 |
Ejemplares similares
-
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
por: Liu, Maoxuan, et al.
Publicado: (2022) -
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Jinhuang, et al.
Publicado: (2015) -
Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
por: Liu, Xinwei, et al.
Publicado: (2016) -
Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014) -
Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)